British Journal of Clinical Pharmacology

Drug regulation & therapeutic efficacy
pp. 801-802(2)
Author: Ritter, J. M.

Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment
pp. 803-810(8)
Authors: Currie, Graeme P.; Butler, Claire A.; Anderson, Wendy J.; Skinner, Chris

Brain histamine H₁ receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with ¹¹C-doxepin
pp. 811-821(11)
Authors: Tashiro, Manabu; Duan, Xudong; Kato, Motohisa; Miyake, Masayasu; Watanuki, Shoichi; Ishikawa, Yoichi; Funaki, Yoshihito; Iwata, Ren; Itoh, Masatoshi; Yanai, Kazuhiko

Eprosartan modulates the reflex activation of the sympathetic nervous system in sodium restricted healthy humans
pp. 822-832(11)
Authors: Vase, Henrik; Lauridsen, Thomas G.; Bech, Jesper N.; Pedersen, Erling B.

Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions
pp. 833-840(8)
Authors: Haller, Christine A.; Duan, Minjing; Jacob, Peyton; Benowitz, Neal

Systemic and bronchodilator effects of inhaled rac-formoterol in subjects with chronic obstructive pulmonary disease: a dose-response study
pp. 841-847(7)
Authors: Whale, Christopher I.; Sovani, Milind P.; Mortimer, Kevin J.; Harrison, Timothy W.; Tattersfield, Anne E.

Safety, tolerability and pharmacokinetics of udenafil, a novel PDE-5 inhibitor, in healthy young Korean subjects
pp. 848-854(7)
Authors: Kim, Bo-Hyung; Lim, Hyeong-Seok; Chung, Jae-Yong; Kim, Jung-Ryul; Lim, Kyoung Soo; Sohn, Dong-Ryul; Cho, Joo-Youn; Yu, Kyung-Sang; Shin, Sang-Goo; Paick, Jae-Seung; Jang, In-Jin

Mechanistic modelling of tesaglitazar pharmacokinetic data in subjects with various degrees of renal function - evidence of interconversion
pp. 855-863(9)
Authors: Hamrén, Bengt; Ericsson, Hans; Samuelsson, Ola; Karlsson, Mats O.

Acute passive cigarette smoke exposure and inhaled human insulin (Exubera^®) pharmacokinetics
pp. 864-870(7)
Authors: Fountaine, Robert; Milton, Ashley; Checchio, Tina; Wei, Greg; Stolar, Marilyn; Teeter, John; Jaeger, Rudolph; Fryburg, David

Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens
pp. 871-878(8)
Author: Hughes, Dyfrig A.

Diclofenac readily penetrates the cerebrospinal fluid in children
pp. 879-884(6)
Authors: Kokki, Hannu; Kumpulainen, Elina; Laisalmi, Merja; Savolainen, Jouko; Rautio, Jarkko; Lehtonen, Marko

Effects of imatinib (Glivec) on the pharmacokinetics of metoprolol, a CYP2D6 substrate, in Chinese patients with chronic myelogenous leukaemia
pp. 885-892(8)
Authors: Wang, Yanfeng; Zhou, Li; Dutreix, Catherine; Leroy, Elisabeth; Yin, Qi; Sethuraman, Venkat; Riviere, Gilles-Jacques; Yin, Ophelia Q. P.; Schran, Horst; Shen, Zhi-Xiang

Population pharmacokinetic modelling for enterohepatic circulation of mycophenolic acid in healthy Chinese and the influence of polymorphisms in UGT1A9
pp. 893-907(15)
Authors: Jiao, Zheng; Ding, Jun-jie; Shen, Jie; Liang, Hui-qi; Zhong, Long-jin; Wang, Yi; Zhong, Ming-kang; Lu, Wei-yue

UGT1A6 genotype-related pharmacokinetics of deferiprone (L1) in healthy volunteers
pp. 908-916(9)
Authors: Limenta, Lie Michael George; Jirasomprasert, Totsapol; Tankanitlert, Jeeranut; Svasti, Saovaros; Wilairat, Prapin; Chantharaksri, Udom; Fucharoen, Suthat; Morales, Noppawan Phumala

The association of adiponectin allele 45T/G and −11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients
pp. 917-926(10)
Authors: Sun, Hong; Gong, Zhi-Cheng; Yin, Ji-Ye; Liu, Hai-Ling; Liu, Ying-Zi; Guo, Zhi-Wei; Zhou, Hong-Hao; Wu, Jing; Liu, Zhao-Qian

Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases
pp. 927-934(8)
Authors: McGettigan, Patricia; Han, Pearline; Jones, Lisa; Whitaker, Diana; Henry, David

Clinically informative measures of the effect of drugs or other interventions
pp. 935-941(7)
Authors: Salmi, L. Rachid; Suissa, Samy; Chêne, Geneviève; Salamon, Roger

Trends in the methodological quality of published randomized controlled trials on antibacterial agents
pp. 942-954(13)
Authors: Falagas, Matthew E.; Pitsouni, Eleni I.; Bliziotis, Ioannis A.

Thrombolysis or nothing for acute myocardial infarction? It's all the same!
pp. 955-958(4)
Authors: Bertele', Vittorio; Angelici, Laura; Barlera, Simona; Garattini, Silvio

Graft rejection: pharmacogenetic analysis or drug anamnesis?
pp. 959-960(2)
Authors: Pham, V. Vi; Stichtenoth, Dirk O.; Borlak, Jürgen

Assessing general practitioners' prescribing behaviour in elderly patients with concealed renal failure
pp. 961-963(3)
Authors: Jonville-Béra, Annie Pierre; Paroux, Lucie; Autret-Leca, Elisabeth

Lean body mass normalizes the effect of obesity on renal function
pp. 964-965(2)
Authors: Janmahasatian, Sarayut; Duffull, Stephen B.; Chagnac, Avry; Kirkpatrick, Carl M. J.; Green, Bruce

A well-tolerated 5-FU-based treatment subsequent to severe capecitabine-induced toxicity in a DPD-deficient patient
pp. 966-970(5)
Authors: Blasco, Hélène; Boisdron-Celle, Michéle; Bougnoux, Philippe; Calais, Gilles; Tournamille, Jean-François; Ciccolini, Joseph; Autret-Leca, Elisabeth; Le Guellec, Chantal

Suspected drug reaction with piperacillin/tazobactam, in a premature infant
pp. 971-972(2)
Authors: Maulidi, Halima; Godambe, Sunit; Chow, Peter

Corrigendum
pp. 973-973(1)

PROCEEDINGS OF THE BRITISH PHARMACOLOGICAL SOCIETY CLINICAL PHARMACOLOGY SECTION 17-20 DECEMBER 2007 HILTON METROPOLE HOTEL, BRIGHTON
pp. 974-1006(33)

AUTHOR INDEX
pp. 1007-1016(10)

SUBJECT INDEX
pp. 1017-1019(3)